Revolution Medicines Ownership | Who Owns Revolution Medicines?

Overview Forecast RevenueFinancials Chart Transcripts

Revolution Medicines Ownership Summary

Revolution Medicines is owned by 101.32% institutional investors, 2.01% insiders. Vanguard group is the largest institutional shareholder, holding 10.25% of RVMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Revolution Medicines shares.

RVMD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Revolution Medicines	101.32%	2.01%	-3.34%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	17.10M	10.25%	$747.80M
Farallon capital management	14.33M	7.61%	$527.04M
Wellington management group llp	10.82M	6.49%	$473.34M
Janus henderson group	9.48M	5.68%	$414.78M
Baker bros. advisors lp	9.36M	4.98%	$344.54M
Blackrock funding, inc. /de	8.66M	4.60%	$318.65M
Nextech invest	7.60M	4.56%	$332.47M
Fmr	6.74M	4.04%	$294.90M
Price t rowe associates inc /md/	5.87M	3.52%	$256.58M
Paradigm biocapital advisors lp	6.18M	3.28%	$218.46M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Mass general brigham	338.19K	63.90%	$13.13M
Nextech invest	7.60M	53.94%	$332.47M
Lunate rsc	2.20M	45.54%	$96.06M
Ah capital management	2.75M	32.32%	$101.12M
Paradigm biocapital advisors lp	6.18M	10.01%	$218.46M
Casdin capital	2.89M	9.68%	$106.25M
Boxer capital	4.28M	8.75%	$166.09M
Checkpoint capital	392.01K	7.61%	$13.86M
Alphabet	4.13M	7.12%	$152.06M
Logos global management lp	1.70M	6.92%	$62.54M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	9.48M	0.21%	3.35M
T. rowe price investment management	4.69M	0.11%	3.02M
Lunate rsc	2.20M	45.54%	2.20M
Vanguard group	17.10M	0.01%	2.19M
Norges bank	1.74M	0.01%	1.74M

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	8.66M	0.01%	-6.03M
Balyasny asset management	-	-	-1.30M
Casdin capital	2.89M	9.68%	-810.00K
Finepoint capital lp	-	-	-691.26K
Perceptive advisors	-	-	-618.88K

New Positions

Holder	Shares	% Assets	Change	Value
Lunate rsc	2.20M	45.54%	2.20M	$96.06M
Norges bank	1.74M	0.01%	1.74M	$76.20M
Vestal point capital, lp	1.20M	2.32%	1.20M	$44.15M
Caligan partners lp	465.00K	3.43%	465.00K	$16.44M
Weiss asset management lp	303.77K	0.13%	303.77K	$11.18M

Sold Out

Holder	Change
Tfc financial management	-1.00
American capital advisory	-6.00
Principal securities	-8.00
Wolff wiese magana	-9.00
Bokf, na	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	318	8.53%	190,637,976	-0.22%	101	0.98%	170	18.06%	89	-
Mar 31, 2025	25	-91.50%	35,140,611	-81.80%	18	0.14%	15	-92.11%	6	-89.09%
Dec 31, 2024	277	5.73%	184,740,316	9.37%	110	1.08%	179	20.95%	52	-16.13%
Sep 30, 2024	260	14.54%	168,886,065	0.30%	101	973278.73%	148	18.40%	62	8.77%
Jun 30, 2024	227	4.13%	168,384,927	6.00%	-	1101.87%	125	20.19%	57	-13.64%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	5.28M	2.82%	-110.56K
Vanguard US Total Market Shares ETF	4.74M	2.55%	4.24K
BB Biotech AG Ord	4.37M	2.37%	-484.46K
iShares Russell 2000 ETF	4.27M	2.29%	-
Vanguard Small Cap Index	4.07M	2.18%	-22.59K
Vanguard Health Care Inv	3.87M	2.08%	-946.03K
Fidelity Growth Compy Commingled Pl S	3.07M	1.65%	317.03K
Janus Inst Mid Cap Growth CF	2.40M	1.29%	377.18K
Janus Henderson Enterprise D	2.40M	1.29%	-
Vanguard Small Cap Growth Index Inv	2.30M	1.23%	-2.23K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 03, 2025	Anders Jack	Chief Financial Officer	Sell	$210.43K
Sep 02, 2025	Anders Jack	Chief Financial Officer	Sell	$190.56K
Jun 20, 2025	Cislini Jeff	General Counsel	Sell	$75.74K
Jun 16, 2025	Horn Margaret A	Chief Operating Officer	Sell	$139.80K
Jun 16, 2025	GOLDSMITH MARK A	See Remarks	Sell	$537.55K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	2
2025 Q2	-	7
2025 Q1	-	7
2024 Q4	2	23
2024 Q3	-	20

RVMD Ownership FAQ

Who Owns Revolution Medicines?

Revolution Medicines shareholders are primarily institutional investors at 101.32%, followed by 2.01% insiders and -3.33% retail investors. The average institutional ownership in Revolution Medicines's industry, Biotech Stocks , is 306.59%, which Revolution Medicines falls below.

Who owns the most shares of Revolution Medicines?

Revolution Medicines’s largest shareholders are Vanguard group (17.1M shares, 10.25%), Farallon capital management (14.33M shares, 7.61%), and Wellington management group llp (10.82M shares, 6.49%). Together, they hold 24.35% of Revolution Medicines’s total shares outstanding.

Does Blackrock own Revolution Medicines?

BlackRock is not among the top 10 institutional shareholders of Revolution Medicines.

Who is Revolution Medicines’s biggest shareholder by percentage of total assets invested?

Mass general brigham is Revolution Medicines’s biggest shareholder by percentage of total assets invested, with 63.90% of its assets in 338.19K Revolution Medicines shares, valued at 13.13M$.

Who is the top mutual fund holder of Revolution Medicines shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Revolution Medicines shares, with 2.82% of its total shares outstanding invested in 5.28M Revolution Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools